LONDON - Oxford BioDynamics PLC (AIM ... The company confirmed that Iain Ross has joined the Board as Executive Chairman, effective immediately. The resolutions passed today follow the company's ...
More than nine out of 10 men who receive a positive EpiSwitch PSE result will have prostate cancer confirmed, said Iain Ross, executive chairman of Oxford BioDynamics. This can “significantly ...